1-O-[β-D-吡喃木糖-(1-6)-β-D-吡喃葡萄糖苷]-8-羟基-3,7-二甲氧基口山酮, 分析对照品, ≥99%(HPLC)

1-O-[β-D-Xylopyranosyl-(1-6)-β-D-glucopyranosyl]-8-hydroxy-3,7-dimethoxyxanthone

N-(6-溴-2-((叔丁基二甲基甲硅烷氧基)甲基)呋喃[3,2-b]吡啶-7-基)新戊酰胺

N-(6-Bromo-2-((tert-butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-7-yl)pivalamide

试剂级

4-溴-2-氟-6-羟基苯甲酸, 98%

4-Bromo-2-fluoro-6-hydroxybenzoic acid

WAY-323260

WAY-323260

10mM in DMSO

4-氨基-1-N-苯基乙基哌啶

4-amino-1-N-phenylethylpiperidine

试剂级

4-甲氧基-2-氰基苯并噻唑, 98%

4-Methoxybenzo[d]thiazole-2-carbonitrile

viniferin

≥95% (LC/MS-ELSD)

≥98%（LC/MS-ELSD）

4-PPBP马来酸酯

4-PPBP maleate

99.9%

3-(3-羧基-5-氟苯基)-5-硝基苯甲酸

3-(3-Carboxy-5-fluorophenyl)-5-nitrobenzoic acid

96%

5'-DMT-AC-5-I-2'-DC, 98%

5-O-(4,4'-Dimethoxytrityl)-N4-acetyl-5-iodo-deoxycytidine

(3S)-(+)-3-(1-甲基-1H-吲哚-3-基)-1-丁醇

0.98

99%

3-O-乙酰基咖啡酸甲酯4-O-（三-O-乙酰基-β-D-葡萄糖醛酸甲酯）

3-O-Acetyl Caffeic Acid Methyl Ester 4-O-(Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester)

(R)-N-Boc-2,2-二甲基-4-(羟甲基)噁唑烷, ≥98%

(R)-N-Boc-4-(hydroxymethyl)-2,2-dimethyloxazolidine

6-氯-N〜4〜-环丙基嘧啶-2,4-二胺

6-chloro-N~4~-cyclopropylpyrimidine-2,4-diamine

5-(2,4-Dimethoxyphenyl)thiophene-2-carbaldehyde, 98%

5-(2,4-Dimethoxyphenyl)thiophene-2-carbaldehyde

(S)-(-)-2-羟基-4-(2-甲氧苯基)-5,5-二甲基-1,3,2-二噁磷己环 2-氧化物

0.97

98%

PtdIns-（3）-P1（1,2-二棕榈酰）-d62（铵盐）

PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 (ammonium salt)

[{2-[（1,3-苯并二恶英-5-基甲基）氨基]-2-氧乙基}（4-甲氧基苯基）氨基]乙酸

[{2-[(1,3-Benzodioxol-5-ylmethyl)amino]-2-oxoethyl}(4-methoxyphenyl)amino]acetic acid

5-(苯基乙炔基)烟酸, 98%

5-(Phenylethynyl)nicotinic acid

2,6-二叔丁基对甲酚, 超纯级,>99.5%(GC)

2,6-Di-tert-butyl-4-methylphenol (BHT)